NDC 0054-0220 Quetiapine Fumarate
Tablet Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0054 - West-ward Pharmaceuticals Corp
- 0054-0220 - Quetiapine Fumarate
Product Characteristics
Product Packages
NDC Code 0054-0220-20
Package Description: 10 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK
Price per Unit: $0.04410 per EA
Product Details
What is NDC 0054-0220?
What are the uses for Quetiapine Fumarate?
What are Quetiapine Fumarate Active Ingredients?
- QUETIAPINE FUMARATE 25 mg/1 - A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER.
Which are Quetiapine Fumarate UNII Codes?
The UNII codes for the active ingredients in this product are:
- QUETIAPINE FUMARATE (UNII: 2S3PL1B6UJ)
- QUETIAPINE (UNII: BGL0JSY5SI) (Active Moiety)
Which are Quetiapine Fumarate Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- POVIDONE K30 (UNII: U725QWY32X)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for Quetiapine Fumarate?
- RxCUI: 312743 - QUEtiapine fumarate 100 MG Oral Tablet
- RxCUI: 312743 - quetiapine 100 MG Oral Tablet
- RxCUI: 312743 - quetiapine (as quetiapine fumarate) 100 MG Oral Tablet
- RxCUI: 312744 - QUEtiapine fumarate 25 MG Oral Tablet
- RxCUI: 312744 - quetiapine 25 MG Oral Tablet
Which are the Pharmacologic Classes for Quetiapine Fumarate?
* Please review the disclaimer below.
Patient Education
Quetiapine
Quetiapine tablets and extended-release (long-acting) tablets are used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Quetiapine tablets and extended-release tablets are also used alone or with other medications to treat episodes of mania (frenzied, abnormally excited or irritated mood) or depression in patients with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). In addition, quetiapine tablets and extended-release tablets are used with other medications to prevent episodes of mania or depression in patients with bipolar disorder. Quetiapine extended-release tablets are also used along with other medications to treat depression. Quetiapine tablets may be used as part of a treatment program to treat bipolar disorder and schizophrenia in children and teenagers. Quetiapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".